Rode Kruis Ziekenhuis

The trials here

What the 7 trials at this site are about, from their registry records.

Conditions

• Heart failure2 trials
• Prostate cancer2 trials
• Atrial fibrillation1 trial
• Chronic kidney disease1 trial
• Colorectal cancer1 trial
• COPD1 trial
• Coronary artery disease1 trial
• Metastatic breast cancer1 trial
• Obesity1 trial
• Peripheral artery disease1 trial
• Stroke1 trial
• Type 2 diabetes1 trial

Phase

• Phase 33 trials
• Phase 42 trials

Status

• Recruiting3 trials
• Active, not recruiting2 trials
• Completed2 trials

Lead sponsor

• Borstkanker Onderzoek Groep1 trial
• Comprehensive Cancer Centre The Netherlands1 trial
• Dutch Colorectal Cancer Group1 trial
• Eli Lilly and Company1 trial
• Huib A.M. Kerstjens1 trial
• and 2 more

Running trials

• Active, not recruiting

  The Effect of Retatrutide Once Weekly on Cardiovascular Outcomes and Kidney Outcomes in Adults Living With Obesity (TRIUMPH-Outcomes)

  NCT06383390· Phase 3· Eli Lilly and Company· Source

• Recruiting

  Apa/Enza-short Study: Shorter Treatment With Androgen Receptor Pathway Inhibitor in Patients With Low-volume Metastatic Castration-sensitive Prostate Cancer

  NCT07260435· Phase 3· Nick Beije· Source

  Contact: Dr. Goosens

• Recruiting

  High-Risk prostatE Cancer radiatiOn Versus surgERy

  NCT05931419· Comprehensive Cancer Centre The Netherlands· Source

  Contact: Berdine Heesterman, MD, PhD

• Active, not recruiting

  Endocrine Therapy Plus CDK4/6 in First or Second Line for Hormone (SONIA) Receptor Positive Advanced Breast Cancer

  NCT03425838· Phase 3· Borstkanker Onderzoek Groep· Source

• Recruiting

  Prospective Data Collection Initiative on Colorectal Cancer

  NCT02070146· Dutch Colorectal Cancer Group· Source

  Contact: A. Goosens

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Prostate cancer2 recruiting
• Colorectal cancer1 recruiting

Closed trials

• Completed

  Digoxin Evaluation in Chronic Heart Failure: Investigational Study In Outpatients in the Netherlands

  NCT03783429· Phase 4· University Medical Center Groningen· Source

• Completed

  Morphine or Fentanyl for Refractory Dyspnea in COPD

  NCT03834363· Phase 4· Huib A.M. Kerstjens· Source